english.prescrire.org > Spotlight > 100 most recent

Spotlight

Every month, the subjects in Prescrire’s Spotlight.

100 most recent :  1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90

Proton pump inhibitors: avoid unjustified risks, and know how to "deprescribe"

Food supplements: too readily authorised and sometimes dangerous

Oral semaglutide (Rybelsus°): more uncertainty than with subcutaneous liraglutide

In the June issue of Prescrire International: Non-metastatic, castration-resistant prostate cancer

Covid-19 drugs and vaccines: big money and winning alliances

Iodine during pregnancy: supplementation should not be systematic

Oral cancer drugs: care provided in community pharmacies

Memantine (Ebixa° and other brands): perception disorders

Pre-exposure prophylaxis for HIV (PrEP): reduction in risk of infection confirmed

Prescrire: independence and transparency, in the name of better patient care

1 | 10 | 20 | 30 | 40 | 50 | 60 | 70 | 80 | 90